- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.06 Å
- Oligo State
- homo-24-mer
- Ligands
- 24 x EXD: 2-(trifluoromethyl)-1H-benzimidazol-7-ol(Non-covalent)
- 60 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 7 residues within 4Å:- Chain A: S.39, P.40, S.41
- Chain F: E.134, R.137, H.138
- Ligands: EXD.1
Ligand excluded by PLIPSO4.3: 4 residues within 4Å:- Chain A: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.4: 2 residues within 4Å:- Chain A: S.121, K.122
Ligand excluded by PLIPSO4.6: 7 residues within 4Å:- Chain B: S.39, P.40, S.41
- Chain H: E.134, R.137, H.138
- Ligands: EXD.5
Ligand excluded by PLIPSO4.7: 4 residues within 4Å:- Chain B: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.8: 2 residues within 4Å:- Chain B: S.121, K.122
Ligand excluded by PLIPSO4.10: 7 residues within 4Å:- Chain C: S.39, P.40, S.41
- Chain G: E.134, R.137, H.138
- Ligands: EXD.9
Ligand excluded by PLIPSO4.11: 4 residues within 4Å:- Chain C: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.12: 2 residues within 4Å:- Chain C: S.121, K.122
Ligand excluded by PLIPSO4.14: 7 residues within 4Å:- Chain D: S.39, P.40, S.41
- Chain E: E.134, R.137, H.138
- Ligands: EXD.13
Ligand excluded by PLIPSO4.15: 4 residues within 4Å:- Chain D: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.16: 2 residues within 4Å:- Chain D: S.121, K.122
Ligand excluded by PLIPSO4.18: 7 residues within 4Å:- Chain E: S.39, P.40, S.41
- Chain J: E.134, R.137, H.138
- Ligands: EXD.17
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain E: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.20: 2 residues within 4Å:- Chain E: S.121, K.122
Ligand excluded by PLIPSO4.22: 7 residues within 4Å:- Chain F: S.39, P.40, S.41
- Chain L: E.134, R.137, H.138
- Ligands: EXD.21
Ligand excluded by PLIPSO4.23: 4 residues within 4Å:- Chain F: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.24: 2 residues within 4Å:- Chain F: S.121, K.122
Ligand excluded by PLIPSO4.26: 7 residues within 4Å:- Chain G: S.39, P.40, S.41
- Chain K: E.134, R.137, H.138
- Ligands: EXD.25
Ligand excluded by PLIPSO4.27: 4 residues within 4Å:- Chain G: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.28: 2 residues within 4Å:- Chain G: S.121, K.122
Ligand excluded by PLIPSO4.30: 7 residues within 4Å:- Chain H: S.39, P.40, S.41
- Chain I: E.134, R.137, H.138
- Ligands: EXD.29
Ligand excluded by PLIPSO4.31: 4 residues within 4Å:- Chain H: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.32: 2 residues within 4Å:- Chain H: S.121, K.122
Ligand excluded by PLIPSO4.34: 7 residues within 4Å:- Chain B: E.134, R.137, H.138
- Chain I: S.39, P.40, S.41
- Ligands: EXD.33
Ligand excluded by PLIPSO4.35: 4 residues within 4Å:- Chain I: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.36: 2 residues within 4Å:- Chain I: S.121, K.122
Ligand excluded by PLIPSO4.38: 7 residues within 4Å:- Chain D: E.134, R.137, H.138
- Chain J: S.39, P.40, S.41
- Ligands: EXD.37
Ligand excluded by PLIPSO4.39: 4 residues within 4Å:- Chain J: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.40: 2 residues within 4Å:- Chain J: S.121, K.122
Ligand excluded by PLIPSO4.42: 7 residues within 4Å:- Chain C: E.134, R.137, H.138
- Chain K: S.39, P.40, S.41
- Ligands: EXD.41
Ligand excluded by PLIPSO4.43: 4 residues within 4Å:- Chain K: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.44: 2 residues within 4Å:- Chain K: S.121, K.122
Ligand excluded by PLIPSO4.46: 7 residues within 4Å:- Chain A: E.134, R.137, H.138
- Chain L: S.39, P.40, S.41
- Ligands: EXD.45
Ligand excluded by PLIPSO4.47: 4 residues within 4Å:- Chain L: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.48: 2 residues within 4Å:- Chain L: S.121, K.122
Ligand excluded by PLIPSO4.50: 2 residues within 4Å:- Chain M: S.121, K.122
Ligand excluded by PLIPSO4.51: 4 residues within 4Å:- Chain M: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.53: 2 residues within 4Å:- Chain N: S.121, K.122
Ligand excluded by PLIPSO4.54: 4 residues within 4Å:- Chain N: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.56: 2 residues within 4Å:- Chain O: S.121, K.122
Ligand excluded by PLIPSO4.57: 4 residues within 4Å:- Chain O: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.59: 2 residues within 4Å:- Chain P: S.121, K.122
Ligand excluded by PLIPSO4.60: 4 residues within 4Å:- Chain P: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.62: 2 residues within 4Å:- Chain Q: S.121, K.122
Ligand excluded by PLIPSO4.63: 4 residues within 4Å:- Chain Q: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.65: 2 residues within 4Å:- Chain R: S.121, K.122
Ligand excluded by PLIPSO4.66: 4 residues within 4Å:- Chain R: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.68: 2 residues within 4Å:- Chain S: S.121, K.122
Ligand excluded by PLIPSO4.69: 4 residues within 4Å:- Chain S: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.71: 2 residues within 4Å:- Chain T: S.121, K.122
Ligand excluded by PLIPSO4.72: 4 residues within 4Å:- Chain T: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.74: 2 residues within 4Å:- Chain U: S.121, K.122
Ligand excluded by PLIPSO4.75: 4 residues within 4Å:- Chain U: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.77: 2 residues within 4Å:- Chain V: S.121, K.122
Ligand excluded by PLIPSO4.78: 4 residues within 4Å:- Chain V: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.80: 2 residues within 4Å:- Chain W: S.121, K.122
Ligand excluded by PLIPSO4.81: 4 residues within 4Å:- Chain W: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.83: 2 residues within 4Å:- Chain X: S.121, K.122
Ligand excluded by PLIPSO4.84: 4 residues within 4Å:- Chain X: H.18, R.91, S.128, S.129
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Moreau, R.J. et al., Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria. J. Med. Chem. (2018)
- Release Date
- 2018-03-14
- Peptides
- Phosphopantetheine adenylyltransferase: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
AI
AJ
AK
AL
AM
BN
BO
BP
BQ
BR
BS
BT
BU
BV
BW
BX
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.06 Å
- Oligo State
- homo-24-mer
- Ligands
- 24 x EXD: 2-(trifluoromethyl)-1H-benzimidazol-7-ol(Non-covalent)
- 60 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Moreau, R.J. et al., Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria. J. Med. Chem. (2018)
- Release Date
- 2018-03-14
- Peptides
- Phosphopantetheine adenylyltransferase: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
AI
AJ
AK
AL
AM
BN
BO
BP
BQ
BR
BS
BT
BU
BV
BW
BX
B